Rights and permissions
About this article
Cite this article
HE 3286 to be evaluated in phase I/II trial of patients with RA. Inpharma Wkly. 1651, 12 (2008). https://doi.org/10.2165/00128413-200816510-00023
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200816510-00023